Accuray announces first patient treated in Melbourne with CyberKnife S7 System

Accuray (ARAY) announced that 5D Clinics has treated the first patients in the city of Melbourne, Australia, using the CyberKnife S7 System. 5D Clinics and joint venture partner Icon Group will open and operate CyberKnife System centers across Australia*, with the goal of making it easier for cancer patients to obtain state-of-the-art precision robotic stereotactic body radiation therapy, or SBRT, and stereotactic radio surgery, or SRS, treatments closer to home. With an initial focus on the East Coast of Australia, the new center in Melbourne is the first to be managed by the JV. The number of new cancer cases diagnosed in Australia is projected to grow from 212,332 in 2022 to 318,285 in 2045, a nearly 50% increase. The rise in patient diagnoses reinforces the need for innovative new treatment options, such as the CyberKnife System, that can effectively manage the disease while improving the care journey and its impact on patients’ quality of life. alphaXRT is the exclusive distributor, installer and training partner for the Accuray CyberKnife and TomoTherapy platform portfolios in Australasia.